Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer
Status:
Recruiting
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
This clinical study will investigate the utility of PET imaging with [89Zr]Panitumumab for
imaging of EGFR expression in newly diagnosed colon cancer patients to assess lymph node
involvement. If promising, this data will be used to design larger trials.